Who is sponsoring NCT03214653?

NCT03214653 is sponsored by Indonesia University.

What drugs are being tested in NCT03214653?

Interventions in NCT03214653: Propofol, Sevoflurane.

What condition does NCT03214653 study?

NCT03214653 studies Renal Transplant Recipient Patients.

Is NCT03214653 still recruiting?

NCT03214653 is currently completed. Last updated 28 February 2018.

Last reviewed 2018-02-28 · How we verify

NCT03214653

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Hemodynamic Profile of Renal Transplant Recipient

Completed NA Last updated 28 February 2018

What this trial tests

NA trial testing Propofol in Renal Transplant Recipient Patients in 23 participants. Completed in 31 January 2018.

Timeline

1 July 2017

Primary endpoint
30 November 2017

31 January 2018

Quick facts

Lead sponsor	Indonesia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	23
Start date	1 July 2017
Primary completion	30 November 2017
Estimated completion	31 January 2018
Sites	1 location across Indonesia

Drugs / interventions tested

Propofol (Propofol) — full drug profile →
Sevoflurane — full drug profile →

Conditions studied

Renal Transplant Recipient Patients — all drugs for Renal Transplant Recipient Patients →

Sponsor

Indonesia University

Who can join

Adults 16 to 65, any sex, with Renal Transplant Recipient Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare the effect of target-controlled infusion of propofol and sevoflurane as maintenance of anesthesia to intraoperative hemodynamic profile of renal transplant recipient

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of the Effects of Target-Controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia on Hemodynamic Profile in Kidney Transplantation.
Aditianingsih D, Sukmono B, Agung TA, Kartolo WY, et al · · 2019 · cited 3× · PMID 31885551 · DOI 10.1155/2019/5629371

Verify or expand the search:

Other trials of Propofol

Trials testing the same drug.

NCT07251101 — Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery · NA · not yet recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07460050 — Comparison of Two Sedative Agents in Terms of Controlled Hypotension · NA · not yet recruiting
NCT07347496 — A Randomized, Controlled Clinical Trial Comparing Remimazolam Besylate Combined With Alfentanil Versus Propofol Combined · Phase 4 · not yet recruiting

Other Indonesia University trials

Trials by the same sponsor.

NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03214653 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indonesia University
Last refreshed: 28 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03214653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing